PART I ITEM 1. B USINESS Overview At Standard BioTools, Inc. ("Standard BioTools" or the "Company"), we are committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world class management team. Our established portfolio includes essential, standardized next-generation solutions designed to help biomedical researchers develop better therapeutics faster. We offer a diverse range of instrumentation, consumables, and ser...
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2025-12-31 | 0001193125-26-108326 | EDGAR | 71K words |
| 2025-03-11 | 2024-12-31 | 0000950170-25-036608 | EDGAR | — |
| 2024-03-01 | 2023-12-31 | 0000950170-24-023845 | EDGAR | — |
| 2023-03-14 | 2022-12-31 | 0001162194-23-000013 | EDGAR | — |
| 2022-03-08 | 2021-12-31 | 0001162194-22-000021 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001162194-21-000013 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001162194-20-000016 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001162194-19-000020 | EDGAR | — |
| 2018-03-08 | 2017-12-31 | 0001162194-18-000032 | EDGAR | — |
| 2017-03-03 | 2016-12-31 | 0001628280-17-002137 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-04 | 2025-09-30 | 0001193125-25-264695 | EDGAR | 27K words |
| 2025-08-15 | 2025-06-30 | 0000950170-25-109388 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064606 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122473 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091888 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-057213 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060385 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001628280-23-028287 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001162194-23-000024 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001162194-22-000098 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001162194-22-000091 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001162194-22-000055 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-24 | 0001193125-26-067026 | EDGAR | 6K words |
| 2026-01-30 | 0001104659-26-008375 | EDGAR | — |
| 2026-01-08 | 0001193125-26-006996 | EDGAR | — |
| 2025-11-04 | 0001193125-25-264693 | EDGAR | — |
| 2025-09-17 | 0001193125-25-206150 | EDGAR | — |
| 2025-09-03 | 0000950170-25-112662 | EDGAR | — |
| 2025-08-11 | 0000950170-25-106636 | EDGAR | — |
| 2025-08-01 | 0000950170-25-101439 | EDGAR | — |
| 2025-06-23 | 0001104659-25-061438 | EDGAR | — |
| 2025-06-20 | 0000950170-25-088519 | EDGAR | — |
213 total filings indexed. 181 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001162194 |
| Ticker | LAB |
| Exchange | Nasdaq |
| SIC | 3826: Laboratory Analytical Instruments |
| Incorporated | DE |
| Website | https://www.standardbio.com |
| Listed | 2011-02-10 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report